Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,641.50

7.35 (0.45%)

, WBA

Walgreens Boots Alliance

$71.71

0.12 (0.17%)

09:18
01/24/19
01/24
09:18
01/24/19
09:18

Jefferies finds nine more Rx licenses for PillPack facility in Arizona

Jefferies analyst Brian Tanquilut says his monthly checks with state boards of pharmacy reveal that PillPack's Arizona facility has been granted nine additional prescription licenses. The analyst expects Amazon (AMZN) will continue to pursue Rx licenses for PillPack's Arizona pharmacy in all the remaining states over the next six months. However, the company will still have to acquire or build a few more mail pharmacies and grow capacity before being able to go live with a consumer pharmacy offering, Tanquilut tells investors in a research note. Further, his monthly webscrape of Amazon's healthcare-related private label products indicates that the company's Solimo offering's growth accelerated significantly month-over-month in January. On private label over-the-counter drugs, Walgreens Boots Alliance (WBA) remains more expensive than Amazon's Basic Care offering, while CVS Health's (CVS) net prices are slightly more competitive due to higher discounting, Tanquilut says.

AMZN

Amazon.com

$1,641.50

7.35 (0.45%)

WBA

Walgreens Boots Alliance

$71.71

0.12 (0.17%)

CVS

CVS Health

$65.63

1.24 (1.93%)

  • 25

    Jan

  • 28

    Jan

  • 31

    Jan

  • 04

    Feb

  • 20

    Feb

  • 03

    Mar

AMZN Amazon.com
$1,641.50

7.35 (0.45%)

01/17/19
MSCO
01/17/19
NO CHANGE
Target $99
MSCO
Overweight
PayPal merchant acceptance lead widened in Q4, says Morgan Stanley
Morgan Stanley analyst James Faucette said that PayPal (PYPL) widened its merchant acceptance lead in Q4 as it added a net of 8 of the U.S.'s top 500 internet retailers while the next largest accepted digital wallet, Amazon Pay (AMZN), lost 4 net merchants this quarter. PayPal now has acceptance at 82% of the top 500 U.S. Internet retailers, up from 81% last quarter, while Amazon's acceptance rate slipped to 12% from 13%. MasterCard's (MA) MasterPass gained 1 net new merchant, Visa Checkout (V) gained no net new merchants and Bitcoin acceptance remained unchanged at 4 of the top 500, Faucette added. The analyst, who think PayPal's acceptance lead and consumers' shift toward online purchases should support total payments volume growth at or above the rate of e-commerce, keeps an Overweight rating on PayPal shares and raised his price target to $99 from $97.
01/22/19
RHCO
01/22/19
NO CHANGE
Target $2250
RHCO
Buy
Amazon.com remains 'compelling' on private label dominance, says SunTrust
SunTrust analyst Youssef Squali kept his Buy rating and $2,250 price target on Amazon.com but raised his outlook for revenue in FY22 to $31B from $25B, noting that he sees the company's private label sales growing strongly with estimated 40% increase this year. The analyst states that Amazon's "rise of private labels and exclusives is one of the least understood / most under-appreciated trends" for the company, and that the competitive advantage derived from it is hard to dislodge. Squali adds that the strategy also strengthens Amazon's "flywheel effect" of proprietary offerings, creates better user experience, and should support its margins over time.
01/23/19
BARD
01/23/19
NO CHANGE
Target $2100
BARD
Amazon Q4 results should be in-line, guidance could be 'noisy,' says Baird
Baird analyst Colin Sebastian said holiday e-commerce trends suggest an in-line Q4 for Amazon, which translates into revenue being at the high end of guidance. However, the analyst believes Q1 guidance could be "noisy". He said recent changes to third-party marketplace/FBA fees, India regulations, and macro softness in the UK could muddy the near-term revenue and margin guidance, which keeps him below consensus for Q1. Sebastian reiterated his Outperform rating and $2,100 price target on Amazon.com shares.
01/17/19
RBCM
01/17/19
NO CHANGE
Target $20
RBCM
United Natural Foods price target lowered to $20 from $24 at RBC Capital
RBC Capital analyst William Kirk lowered his price target on United Natural Foods (UNFI) to $20 and kept his Sector Perform rating after its ICR conference presentation. The analyst notes that while the discussions supported his view of "favorable macro trends" in terms of freight, gas, and inflation costs, he is concerned with the risk around the company's "out-year synergies" around the integration of its Supervalu acquisition. Kirk further warns that Amazon (AMZN) Whole Foods combination has the "ability, incentive, and precedent history to de-emphasize" United Natural Foods business.
WBA Walgreens Boots Alliance
$71.71

0.12 (0.17%)

01/23/19
LOOP
01/23/19
NO CHANGE
Target $82
LOOP
Buy
Walgreens already reserved for DOJ settlement, says Loop Capital
After speaking with management at Walgreens Boots Alliance regarding the unsealing of the company's $269M settlement with the Department of Justice for overbilling, Loop Capital analyst Andrew Wolf said his key takeaways were that the fines were already reserved for, so there should be no go-forward financial impact, and that company's most recent 10-Q had referenced the matter. Wolf, who views the unsealing of the settlement as "a final and more specific rendering of previously released news," does not expect the news to have a material impact on the stock. He keeps a Buy rating and $82 price target on Walgreens shares.
01/16/19
MSCO
01/16/19
NO CHANGE
MSCO
Morgan Stanley says UnitedHealth, Walgreens could benefit from CVS-Walmart fight
After CVS Health (CVS) announced Walmart (WMT) will leave Caremark's commercial and Managed Medicaid retail pharmacy networks at the end of April 2019, analysts at Morgan Stanley discussed the potential impact of the fight to both companies and to competitors. Analyst Ricky Goldwasser said the dispute "brings back memories" of the Express Scripts (ESRX) and Walgreens (WBA) breakup in 2011, but unlike in that case it is only the early days of the 2019/2020 selling season, not after the selling season concluded. Walmart's plans to leave should have a limited impact on CVS' FY19 EPS power, but adds uncertainty to PBM selling season if not resolved in the near-term, said Goldwasser. Morgan Stanley's Simeon Gutman said that if the dispute is not resolved, it could end up reducing Walmart's EBIT by about $260M in 2019, which he estimates could have a 7c, or 1.5%, impact on EPS. In terms of who may benefit if no resolution is reached, the team estimates both Walgreens and CVS retail could gain an incremental 25 bps of pharmacy share and that UnitedHealth's (UNH) Optum and Cigna (CI) could see a step up in PBM selling season win rates. However, given Walmart's relatively low share, they view the PBM share opportunity as "minimal."
01/17/19
01/17/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tencent Music (TME) initiated with an Overweight at JPMorgan. 2. Craft Brew (BREW) initiated with a Buy at Maxim while Castle Brands (ROX) was initiated with a Hold. 3. CVS Health (CVS) and LabCorp (LH) were initiated with a Buy at UBS while Walgreens Boots Alliance (WBA) was initiated with a Sell. 4. DTE Energy (DTE) initiated with a Buy at Goldman Sachs while CMS Energy (CMS) was initiated with a Neutral. 5. Zendesk (ZEN) and HubSpot (HUBS) were initiated with an Overweight at Stephens while Adobe (ADBE) was initiated with an Equal Weight. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/17/19
UBSW
01/17/19
INITIATION
Target $70
UBSW
Sell
Walgreens Boots Alliance initiated with a Sell at UBS
UBS analyst Kevin Caliendo started Walgreens Boots Alliance with a Sell rating and $70 price target. The analyst's work suggests the company's core retail margins will stay pressured over the next several years. Further, he believes Walgreens' industry dynamics remain challenging.
CVS CVS Health
$65.63

1.24 (1.93%)

01/14/19
COWN
01/14/19
NO CHANGE
Target $103
COWN
Outperform
CVS Health headwind concerns overblown, says Cowen
Cowen analyst Charles Ryhee updated his model on CVS (CVS) to reflect headwinds from rebate guarantees and Aetna's (AET) large group rated business. He believes the pressure on the shares due to rebate guarantees is overdone in that it represents less than 2% of its revenues. Ryhee reiterated his Outperform rating and $103 price target on CVS shares.
01/17/19
UBSW
01/17/19
INITIATION
Target $75
UBSW
Buy
CVS Health initiated with a Buy at UBS
UBS analyst Kevin Caliendo started CVS Health with a Buy rating and $75 price target. Concerns around 2019 earnings guidance and the timing of the next positive catalyst have pushed CVS stock down to a "very appealing" risk/reward profile, Caliendo tells investors in a research stone.

TODAY'S FREE FLY STORIES

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

09:40
04/26/19
04/26
09:40
04/26/19
09:40
On The Fly
The Intersection: Crypto and Wall Street This Week »

As bitcoin, ethereum and…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

SSNLF

Samsung

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

JPM

JPMorgan

$113.62

(0.00%)

AMD

AMD

$27.66

(0.00%)

NVDA

Nvidia

$186.84

(0.00%)

OSTK

Overstock.com

$13.13

(0.00%)

DPW

DPW Holdings

$0.22

(0.00%)

KODK

Kodak

$2.38

(0.00%)

IDEX

Ideanomics

$1.84

(0.00%)

RIOT

Riot Blockchain

$5.90

(0.00%)

TEUM

Pareteum

$3.90

(0.00%)

SRAX

Social Reality

$4.80

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 30

    Apr

  • 07

    May

  • 09

    May

  • 14

    May

  • 15

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 28

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

  • 10

    Jun

  • 11

    Jun

  • 24

    Jun

  • 25

    Jun

  • 16

    Jul

F

Ford

$9.41

(0.00%)

, JNPR

Juniper

$28.12

(0.00%)

09:40
04/26/19
04/26
09:40
04/26/19
09:40
Options
Unusually active option classes on open April 26th »

Unusual total active…

F

Ford

$9.41

(0.00%)

JNPR

Juniper

$28.12

(0.00%)

WMT

Walmart

$103.52

(0.00%)

INTC

Intel

$57.59

(0.00%)

GRUB

GrubHub

$69.83

(0.00%)

AMZN

Amazon.com

$1,902.53

(0.00%)

MRVL

Marvell

$25.42

(0.00%)

XOM

Exxon Mobil

$82.25

(0.00%)

KR

Kroger

$25.77

(0.00%)

WDC

Western Digital

$52.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 29

    Apr

  • 01

    May

  • 03

    May

  • 06

    May

  • 08

    May

  • 09

    May

  • 10

    May

  • 14

    May

  • 16

    May

  • 16

    May

  • 21

    May

  • 22

    May

  • 28

    May

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 07

    Jun

  • 24

    Jul

  • 25

    Jul

  • 23

    Oct

  • 13

    Nov

09:40
04/26/19
04/26
09:40
04/26/19
09:40
General news
Fed Policy Outlook: analysts continue to take issue with the market's dovish bet »

Fed Policy Outlook:…

AAPL

Apple

$205.28

-1.82 (-0.88%)

09:39
04/26/19
04/26
09:39
04/26/19
09:39
Recommendations
Apple analyst commentary  »

Apple incentives not much…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 03

    Jun

HIBB

Hibbett Sports

$20.53

0.13 (0.64%)

, TSCO

Tractor Supply

$105.09

1 (0.96%)

09:37
04/26/19
04/26
09:37
04/26/19
09:37
Hot Stocks
Hibbett Sports names Christine Skold as Interim CFO, effective April 26 »

Hibbett Sports (HIBB)…

HIBB

Hibbett Sports

$20.53

0.13 (0.64%)

TSCO

Tractor Supply

$105.09

1 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 15

    May

  • 23

    May

  • 25

    Jul

  • 13

    Nov

SBUX

Starbucks

$77.07

0.65 (0.85%)

09:37
04/26/19
04/26
09:37
04/26/19
09:37
Hot Stocks
Starbucks CEO says competitor discounts in China not sustainable »

Kevin Johnson is speaking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$161.03

-0.47 (-0.29%)

09:36
04/26/19
04/26
09:36
04/26/19
09:36
Recommendations
Visa analyst commentary at BMO Capital »

Visa price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

  • 29

    May

  • 05

    Jun

WNS

WNS Holdings

$56.71

0.26 (0.46%)

09:36
04/26/19
04/26
09:36
04/26/19
09:36
Recommendations
WNS Holdings analyst commentary  »

WNS Holdings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

ANTM

Anthem

$256.01

5 (1.99%)

, CVS

CVS Health

$53.24

0.31 (0.59%)

09:34
04/26/19
04/26
09:34
04/26/19
09:34
Recommendations
Anthem, CVS Health analyst commentary at Cleveland Research »

Anthem won Blue Cross of…

ANTM

Anthem

$256.01

5 (1.99%)

CVS

CVS Health

$53.24

0.31 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 01

    May

  • 07

    May

  • 15

    May

  • 16

    May

  • 19

    May

  • 29

    May

  • 18

    Jun

RL

Ralph Lauren

$129.74

-2.31 (-1.75%)

09:34
04/26/19
04/26
09:34
04/26/19
09:34
Upgrade
Ralph Lauren rating change  »

Ralph Lauren upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

SFLY

Shutterfly

$42.30

-0.65 (-1.51%)

09:32
04/26/19
04/26
09:32
04/26/19
09:32
Upgrade
Shutterfly rating change  »

Shutterfly upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

HTBK

Heritage Commerce

09:32
04/26/19
04/26
09:32
04/26/19
09:32
Downgrade
Heritage Commerce rating change  »

Heritage Commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

SIVB

SVB Financial

$247.10

-1.84 (-0.74%)

09:32
04/26/19
04/26
09:32
04/26/19
09:32
Downgrade
SVB Financial rating change  »

SVB Financial downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

  • 09

    May

MAS

Masco

$37.50

-2.48 (-6.20%)

09:32
04/26/19
04/26
09:32
04/26/19
09:32
Upgrade
Masco rating change  »

Masco upgraded two levels…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

FLGT

Fulgent Genetics

$7.23

-0.02 (-0.28%)

09:31
04/26/19
04/26
09:31
04/26/19
09:31
Downgrade
Fulgent Genetics rating change at Credit Suisse »

Fulgent Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

PRO

Pros Holdings

$45.06

-0.25 (-0.55%)

09:30
04/26/19
04/26
09:30
04/26/19
09:30
Recommendations
Pros Holdings analyst commentary  »

ProsHoldings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

CLS

Celestica

$7.29

-1.315 (-15.28%)

09:28
04/26/19
04/26
09:28
04/26/19
09:28
Downgrade
Celestica rating change at Canaccord »

Celestica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHW

Sherwin-Williams

$451.24

-6.61 (-1.44%)

09:27
04/26/19
04/26
09:27
04/26/19
09:27
Conference/Events
Sherwin-Williams management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

CARO

Carolina Financial

$36.08

-0.83 (-2.25%)

09:26
04/26/19
04/26
09:26
04/26/19
09:26
Downgrade
Carolina Financial rating change  »

Carolina Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGO

Argo Group

$74.21

-0.245 (-0.33%)

09:26
04/26/19
04/26
09:26
04/26/19
09:26
Upgrade
Argo Group rating change at William Blair »

Argo shares could double…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 11

    Jun

POWI

Power Integrations

$78.11

-1.93 (-2.41%)

09:25
04/26/19
04/26
09:25
04/26/19
09:25
Recommendations
Power Integrations analyst commentary at Loop Capital »

Power Integrations price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 22

    May

HPE

HP Enterprise

$16.00

-0.27 (-1.66%)

09:25
04/26/19
04/26
09:25
04/26/19
09:25
Conference/Events
HP Enterprise management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 09

    Jul

09:25
04/26/19
04/26
09:25
04/26/19
09:25
General news
Today's U.S. GDP report »

Today's U.S. GDP…

HFWA

Heritage Financial

$30.77

-0.6 (-1.91%)

09:23
04/26/19
04/26
09:23
04/26/19
09:23
Downgrade
Heritage Financial rating change at Sandler ONeill »

Heritage Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

TAL

TAL Education

$36.22

1.81 (5.26%)

09:22
04/26/19
04/26
09:22
04/26/19
09:22
Upgrade
TAL Education rating change  »

TAL Education upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.